Cancer Immunotherapy: Timing Could Make a Difference
But here’s the surprising part: when immunotherapy is given may influence how well it works. A new study suggests that administering IV immunotherapy earlier in the day could lead to longer survival for lung cancer patients.
Key points
- Timing may boost immunotherapy effectiveness
- Lung cancer patients treated before 3 p.m. had longer remissions and better survival
- The potential impact is significant and could be implemented without extra costs
Researchers reported online on December 8, 2025 in Cancer that patients with advanced small cell lung cancer who received atezolizumab or durvalumab alongside standard chemotherapy earlier in the day tended to live longer. In the study, which included about 400 patients treated between May 2019 and October 2023, those who received the IV drugs before 3 p.m. showed a notably lower risk of cancer progression and death compared with those treated later in the day.
Dr. Yongchang Zhang, a senior researcher and associate professor at the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University in China, commented that adjusting infusion timing is a simple, cost-free change that could be adopted across various healthcare settings. He noted the finding has immediate clinical relevance and could alter current treatment protocols for small cell lung cancer.
Experts say the most likely reason behind this effect is circadian rhythm—the body’s internal clock that modulates immune responses and other biological processes. While the results are compelling, more research is needed to fully understand how circadian timing interacts with cancer therapies and how best to leverage a patient’s clock to maximize benefit.
Bottom line for patients: if you’re undergoing immunotherapy, discuss with your oncology team whether morning or early afternoon infusions might be feasible and advantageous for your treatment plan.
Why this matters
- If confirmed in further studies, timing could become a simple, low-cost way to improve outcomes for people receiving cancer immunotherapy.
- The study highlights a broader concept: aligning medical treatment with the body’s natural rhythms may enhance effectiveness in oncology and beyond.
Additional resources
- American Cancer Society: overview of immunotherapy
SOURCES: American Cancer Society; HealthDay News; Cancer, December 8, 2025
Would you consider discussing infusion timing with your doctor, and what questions would you want to ask regarding morning versus afternoon treatments?
